Location: Home > Pharma China Web Edition
  • search
  • go
    • Industry News
    SciClone reports rising Zadaxin sales in China 3/6/2006
    SciClone Pharmaceuticals, Inc. reported a Q4 net loss of 4 cents a share, up from a loss of 5 cents a share in the year-ago period on revenue growth and a 22% jump in sales of Zadaxin, SciClone's lead product. The company predicted Zadaxin sales will advance to about $32 million in 2006, driven by continued growth in China.
    Relate News
    more
  • Site map | Contact Us | Links
  • © Wicon International Group